TYK2 and fungal infectious disease: Inhibiting Tyk2 activation might be associated with an ideal balance between efficacy and safety because individuals with deactivating genetic variants of Tyk2 are highly protected from some IMIDs but do not exhibit an increased risk of hospitalization for mycobacterial, viral, or fungal infections [23,24,25,26,27].